As rates of CRC skyrocket in young individuals, means of addressing the growing problem must be considered.
Jeffrey Reese
Advertisement
Articles by Jeffrey Reese
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
ERS Posters Showcase Nerandomilast Benefits in IPF, ILD
5
